Epilepsy&Behavior148(2023)109486
ContentslistsavailableatScienceDirect
Epilepsy & Behavior
journal homepage: www.elsevier.com/locate/yebeh
Perspective
Non-electroencephalogram-based seizure detection devices: State of the
art and future perspectives
Pirgit Meritam Larsena,1, Sándor Beniczkya,b,1,⇑
aDepartmentofClinicalNeurophysiology,DanishEpilepsyCentre,VisbysAllé5,4293Dianalund,Denmark
bDepartmentofClinicalNeurophysiology,AarhusUniversityHospital,andDepartmentofClinicalMedicine,AarhusUniversity,PalleJuul-JensensBoulevard165,
8200Aarhus,Denmark
a r t i c l e i n f o a b s t r a c t
Articlehistory: Introductionandpurpose: Thecontinuouslyexpandingresearchanddevelopmentofwearabledevicesfor
Revised6October2023 automated seizure detection in epilepsy uses mostlynon-invasivetechnology. Real-time alarms, trig-
Accepted7October2023 geredbyseizuredetectiondevices,areneededforsafetyandpreventiontodecreaseseizure-relatedmor-
Availableonline17October2023
bidityandmortality,aswellasobjectivequantificationofseizurefrequencyandseverity.Ourreview
strivestoprovideastate-of-the-artonautomatedseizuredetectionusingnon-invasivewearabledevices
Keywords: inanambulatory(home)environmentandtohighlighttheprospectsforfutureresearch.
Seizuredetection
Methods: AjointworkinggroupoftheInternationalLeagueAgainstEpilepsy(ILAE)andtheInternational
Wearabledevices
FederationofClinicalNeurophysiology(IFCN)recentlypublishedaclinicalpracticeguidelineonauto-
Epilepsy
matedseizuredetectionusingwearabledevices.Weupdatedthesystematicliteraturesearchfortheper-
iodsincethelastsearchbythejointworkinggroup.Weselectedstudiesqualifyingminimallyasphase-2
clinical validation trials, in accordance with standards for testing and validation of seizure detection
devices.
Results: High-levelevidence(phases3and4)isavailableonlyforthedetectionoftonic-clonicseizures
andmajormotorseizureswhenusingwearabledevicesbasedonaccelerometry,surfaceelectromyogra-
phy(EMG),oramultimodaldevicecombiningaccelerometryandheartrate.Thereportedsensitivityof
thesedevicesis79.4–96%,withafalsealarmrateof0.20–1.92per24hours(0–0.03pernight).Asingle
phase-3studyvalidatedthedetectionofabsenceseizuresusingasingle-channelwearableEEGdevice.
Twophase-4studiesshowedoverall usersatisfaction withwearableseizure detectiondevices, which
helpeddecreaseinjuriesrelatedtotonic-clonicseizures.Overallsatisfaction,perceivedsensitivity,and
improvementinquality-of-lifeweresignificantlyhigherforvalidateddevices.
Conclusions: Amongthevastnumberofstudiespublishedonseizuredetectiondevices,mostarestrongly
affectedbypotentialbias,providingatoo-optimisticperspective.Byapplyingthestandardsforclinical
validationstudies,potentialbiascanbereduced,andthequalityofacontinuouslygrowingnumberof
studiesinthisfieldcanbeassessedandcompared.TheILAE-IFCNclinicalpracticeguidelineonauto-
matedseizuredetectionusingwearabledevicesrecommendsusingclinicallyvalidatedwearabledevices
forautomateddetectionoftonic-clonicseizureswhensignificantsafetyconcernsexist.Thestudiespub-
lishedaftertheguidelinewasissuedonlyprovideincrementalknowledgeandwouldnotchangethecur-
rentrecommendations.
(cid:1)2023TheAuthor(s).PublishedbyElsevierInc.ThisisanopenaccessarticleundertheCCBY-NC-ND
license(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1.Introductionandpurpose aspectsofourdailyactivities,fromnavigationandcommunication
to education and entertainment. This technical revolution has
Mobile technology and smart wearable devices have changed reached health applications and medicine, including neurology
the way we live and have become indispensable tools in many [1–3]. Inthe fieldof epilepsy,most researchand development of
wearableshasbeenfocusedonautomatedseizuredetectionusing
non-invasive devices. Numerous survey studies have demon-
⇑ Correspondingauthorat:VisbysAllé5,4293Dianalund,Denmark. stratedthatpeoplewithepilepsy,aswellastheircaregivers,need
E-mail addresses: pmer@filadelfia.dk (P. Meritam Larsen), sbz@filadelfia.dk such devices [4–8], for preventing or reducing morbidity and
(S.Beniczky).
1 MembersoftheEuropeanReferenceNetworkEpiCare.
https://doi.org/10.1016/j.yebeh.2023.109486
1525-5050/(cid:1)2023TheAuthor(s).PublishedbyElsevierInc.
ThisisanopenaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/4.0/).P.MeritamLarsenandSándorBeniczky Epilepsy&Behavior148(2023)109486
mortalityassociatedwithseizures,andforobjectivequantification validation of seizure detection devices [20]. By adapting the key
ofseizurefrequencyandseverity[9–11]. domains of the QUADAS-2 tool (quality assessment of diagnostic
Real-time alarms, triggered by seizure detection devices, are accuracystudies)[21]tothespecificapplicationofseizuredetec-
neededforsafetyandpreventiontodecreaseseizure-relatedmor- tion devices, standards for clinical validation studies have been
bidityandmortality.Thisisespeciallythecasefortonic-clonicsei- proposed [20]. The key features are as follows: patient selection
zures (generalized tonic-clonic seizures and focal-to-bilateral (subjects),recordingdevices,flowofanalysisandalarms,andref-
tonic-clonic seizures). More than half of the patients with tonic- erence standard. For each of these features, study designs with
clonic seizures experience yearly accidental injuries related to decreasing levels of potential bias have been listed. Using these
theirseizures,and25%ofthemexperienceaseriousinjuryrequir- features,fivephases(0–4)havebeenproposed,similartodrugtri-
inghospitalization,surgicalintervention,orresultinginincapaci- als,wherephase-3studiesprovidecompellingevidenceaboutthe
tation [12]. The odds ratio for injuries is 3.5 times higher in accuracyof the seizuredetectiondevice,and phase-4 studiesare
patientswithfiveormoretonic-clonicseizuresperyear,compared open-label, in-field studies, in the home environment of the
withpatientswhoonlyhaveoneseizureperyear[12].Tonic-clonic patients [20]. To qualify for phase 3, the clinical validationstudy
seizures constitute the major risk factor for Sudden Unexpected must be prospective, multicenter, enrolling at least 20 patients
DeathinEpilepsyPatients(SUDEP).AllSUDEPcasesdocumented with at least 30 seizures (assuming a detection sensitivity over
withvideo-EEGoccurredafteratonic-clonicseizure[13].Experi- 95%),usingapre-definedalgorithmanddetection-threshold,con-
encingtonic-clonicseizuresduringtheprecedingyearwasassoci- tinuouslyrunningin real-timeonthededicatedwearable device,
ated with a 27-fold increase in the risk of SUDEP, while no and comparing the detections with the reference standard from
increased risk was found in patients with other seizure types videoorvideo-EEGrecordings[20].Therequirementsforphase2
[14]. Patients withatleast onetonic-clonicseizureper yearwho studiesarelessstrict,buttheuseofadedicatedseizuredetection
do not share a bedroom have a 67-fold increased risk of SUDEP deviceisneeded,anditssafetyhastobeaddressed.Retrospective
[14],theriskincreasingwiththefrequencyoftonic-clonicseizures analysisandusingthesamedatasetfortrainingandvalidationare
[15]. still allowed at this phase. The number of patients with seizures
Patientsareoftenunabletorecalltheirseizures,andthedegree needstobetenormore,includingatleast15seizuresintheanal-
ofrecallcanshowstrongintra-individualvarianceovertime[16]. ysis.Thereisastrictneedforareferencestandard[20].
Bothunder-andover-reportingmayoccur,andtheinaccuratedoc- Phases3and4studieswerepreviouslycategorizedbytheILAE-
umentation of seizure frequency affects therapeutic decisions in IFCN guidelineworking group as ‘‘high level” evidence in GRADE
dailyclinicalpractice,questioningthereliabilityoflargedrugstud- terms, while phase 2 studies were categorized as ‘‘moderate evi-
ies, which are typically based on patient-reported seizure fre- dence”.Inthisreviewpaper,wefollowedthesameprinciples. In
quency [9]. Studies in the Epilepsy Monitoring Units (EMU), thisreviewpaper,wesummarizeandciteallphases3and4stud-
wherethegoldstandardforseizurefrequencywasavailablefrom iespublishedsincetheclinicalpracticeguideline.Phase-2studies,
video-electroencephalogram(EEG)recordings,showedthatfewer per definition, would not change the recommendation in the
than half of the patients provided complete seizure reports, and guideline,andthedetaileddescriptionofallphase-2studieswas
fewerthanhalfofallobjectivelydetectedseizureswerereported beyond the limitations of this paper. However, we describe
[9].Thiswasmainlythecaseforfocalimpairedawarenessseizures selectedphase-2studies,which,inouropinion,arelikelytolead
(73%unreported)andtonic-clonicseizures(42%unreported)[17]. to further significant development in the future. Phase-2 studies
Impairedrecallofseizureswasmainlyfoundfornocturnalseizures addressingmodalitiesanddetectionstrategiesthatwerereported
(86%)butoccurredevenindaytimeseizures(32%)[17].Anobjec- in phase-3 studies were not described in this paper to avoid
tivequantificationofseizurefrequencyandseverityisneededfor redundancy.
fine-tuning medication tailored to the individual patient and for
reliableevaluationoftherapeuticinterventions[9,11].
Theaimofourreviewistoprovideastate-of-the-artonauto- 3.Results
mated seizure detection using non-invasive wearable devices in
anambulatory(home)environmentandtohighlighttheprospects The ILAE-IFCN joint working group´s search in October 2019
forfutureresearch. gave1,750studies,ofwhichonly28werephases2–4.High-level
evidence(phases3and4)wasonlyavailableforthedetectionof
tonic-clonicseizuresusingwearabledevicesbasedonaccelerome-
2.Methods try,surfaceelectromyography(EMG),oramultimodaldevicecom-
bining accelerometry and heart rate (Table-1). The sensitivity of
AjointworkinggroupoftheInternationalLeagueAgainstEpi- these devices for detecting tonic-clonic seizures was between
lepsy (ILAE) and the International Federation of Clinical Neuro- 90% and 96%, with a false alarm rate of 0.20–0.67 per 24 hours
physiology (IFCN) has recently published a clinical practice (0–0.03pernight).Aphase-4studyshowedthattheuseofawear-
guidelineonautomatedseizuredetectionusingwearabledevices able device in the home environment of the patients helped
[18,19].Thejointworkinggroupdidasystematicreviewoftheevi- decrease injuries related to tonic-clonic seizures in 44% of the
dence,includingpaperspublishedbeforeOctober16,2019(dateof patients,alertingforseizuresthatotherwisewouldhaveremained
lastsearch). unnoticedin55%ofthepatients[22].Forotherseizuretypes,only
HereweupdatedthesystematicliteraturesearchinPubMedfor phase2studieswerefound:usingnoninvasivedevices,sensitivity
theperiodsincethelastsearchbythejointworkinggroup,includ- >90% was achieved using heart rate and heart rate variability
ing articles published from October 2019 until August 2023, by [23,24].Thehighsensitivitywasatthecostoffrequentfalsealarms
using the same search string as used by the ILAE-IFCN working (upto500falsealarmsperday).
group: ((automated detection) OR (algorithm AND detection) OR ByupdatingthesystematicliteraturesearchfromOctober2019
(wearableANDdetection))AND(epilepsyORseizure). untilAugust2023,wefurtherfoundtwophase-4studiesassessing
Similarly, for the joint working group, we did a systematic theperformanceofwearableseizuredetectiondevicesinahome
reviewoftheupdatedevidenceandselectedstudiespublishedin setting [32,33]. Westrhenen et al., 2023 [32] demonstrated high
peer-reviewed journals, qualifying minimally as phase 2 clinical sensitivity (100% median per participant) with a false alarm rate
validation trials, in accordance with standards for testing and at 0.04 per h (median per patient) for nocturnal motor seizures
2P.MeritamLarsenandSándorBeniczky Epilepsy&Behavior148(2023)109486
in children, using a multimodal device including accelerometry alarmrate(0.53perh),themajorityofpatientsdidnotexperience
and heart rate detection (NightWatch), reducing caregiver stress anyfalsealarmsatall.
butnotshowingasignificanteffectonthequalityoflife(QoL)or Even though most studies published on seizure detection
sleepofthecaregivers.Hadadyetal.,2022[33]basedtheirstudy devices do not fulfill the criteria for phase 3 or 4 studies, there
onanonlinequestionnaireincludingahighnumberofuserswho areseveralthatshowpromisingresultsusingvariousmodalities:
had real-world experiencewith using wearable seizure detection accelerometry combination with either photoplethysmography
devicesintheirhomeenvironment.Thisstudyshowedoveralluser [36] or electrodermal activity [37], photoplethysmography alone
satisfaction with their respective wearable device (different [38], ECG [39–41], heart rate variability [42,43], behind-the-ears
devices),aswellasimprovedQoL.Mostusersexperiencedseizure EEG alone [44,45] and in combined with ECG [46,47], and auto-
detection sensitivity that was close to what previous validation matedvideoanalysis[48,49].Phase-2studiesaddressedthequan-
studies had shown, as well as a relatively low false alarm rate tificationofseizureburdenusinganautomatedapproachbasedon
(0–0.43 per day). Overall satisfaction, perceived sensitivity, and EMG combined with accelerometry in patients with progressive
improvement in QoL were significantly higher amongst partici- myoclonicepilepsy[50]andasemiautomatedmethodforquanti-
pants using validated devices (Empatica, Epi-Care, and Night- fying the burden of absence seizures using behind-the-ears EEG
Watch). Most of the patients wearing a device had tonic-clonic [51]. An algorithm based on heart rate and oxygen saturation
seizures (87%). One-third of people with epilepsy experienced achievedgoodresults(sensitivityof87%)[52].However,theinput
fewer seizure-related injuries, and two-thirds experienced was based on conventional measurements and not a dedicated
improvementsintheaccuracyofseizurediariesasaresultofusing wearabledevice.AstudybyFrankeletal.,2021[53]showspoten-
adetectiondevice.Besidestheaforementionedstudies,wefound tial for identifying focal-onset seizures, with experts blindly
two other studies [34,35] addressing device performance and/or reviewing data collected from a miniature, wireless, wearable
user satisfaction in the home environment, though they did not EEG sensor. Furthermore, a unique study by Chen et al., 2023
fulfillthecriteriaforaphase4study.Maceaetal.,2023[34]eval- [54]showedamorefavorableperformanceofamultimodaldetec-
uated focal seizure detection based on behind-the-ear EEG, with tion platform in detecting neonatal seizures by combining data
lowsensitivity(23%)andhighfalsealarmrates(7.8%perh),ona from the ECG, respiration, and accelerometer than compared to
relatively small number of patients (n = 16), thus not qualifying data from a single modality. Unfortunately, the number of neo-
as a phase 4 study. The in-hospital part of the study qualifies as nates experiencing seizures was small (4 patients, 30 seizures),
aphase2study(16patients,21seizures),alsopresentinglowsen- whichmighthaveresultedinalowsensitivityvalue(40%).Another
sitivity(52%),and highfalse alarmrates (7%perh). Accordingto noteworthyproof-of-conceptstudybyJeppesenetal.,2023(phase
user evaluation, the likelihood of using the device in 6 months’ 1 study) [55] presents an automated seizure detection method
time was 62%, mostly due to side effects and low performance. usingasubcutaneouslyimplantablecardiacmonitor.Theydemon-
Engelgeeretal.,2022[35]presentedaneconomicevaluationofa strate a high sensitivity (92.6%) in detecting focal seizures with
multimodal seizure detection device (NightWatch), showing that autonomic ictal changes. One recent pilot study [56] assessed
deviceusagesavescostsandreducesstress,suggestingthisdevice out-of-hospital detection of focal impaired awareness seizures
is a cost-effective addition to current standard care for children with a motor component using a multimodal approach (ECG,
withrefractoryepilepsylivingathome.Thisstudyhadaprimarily accelerometry, and behind-the-ear EEG). The study included 17
economic focus and did not assess device performance regarding patients with focal impaired awareness motor seizures, with
seizurequantificationorotheraspectsofutilityandusability,thus results showing sensitivity at 91% but a high false alarm rate of
notqualifyingasaphase4study. 18/24h.Anotherstudyevaluatedhowdifferentmodalitiescorre-
We found four phase-3 studies and 24 phase-2 studies, pub- latewithdifferenttypesofseizures[57].Clusteranalysisshowed
lishedaftertheprevioussystematicreviewbytheILAE-IFCNwork- trends of greatest elevation of heart rate (HR) and accelerometry
ing group. All phase-3studies (Table 1) have comparable results. (ACC) in bilateral tonic-clonic seizures (BTCs), compared to non-
Onephase-3studyincludedalargenumberofpatients(n=152; BTCsandisolatedauras.HRandACCwereindependentpredictors
85pediatric,67adults)anddetectedtonic-clonicseizuresusinga for overall seizure types (BTCs and non-BTCs), whereas only HR
multimodal device, combining accelerometry with electrodermal wasapredictorforisolatedauras.Diagnosticperformance,includ-
activity [28]. Lazeron et al., 2022 [30] used a multimodal device ing sensitivity, specificity, and area under the receiver operating
withheartratedetectionandaccelerometrytoassessthedetection characteristic(ROC)curveofthepredictivemodelforoverallsei-
of nocturnal major motor seizures in children with epilepsy and zures, was 77.78%, 60%, and 0.696 (95% confidence interval = 0.6
intellectual disability. The high false alarm rate seen in children 28–0.764), respectively. A study by Halimeh et al., 2023 [58]
in their study, as well as in a previous study [26], was largely showed that using prolonged postictal data (increased levels of
duetotheheartratepartofthealgorithm.Byoptimizingthealgo- electrodermalactivityandheartratelongafterseizureEEGonset)
rithm(thealarmwastriggeredonlywhenthepatientwasinahor- segmentsforseizureloggingcancontributetoalgorithmexplain-
izontal position), theysucceededin reducingthefalse alarmrate ability and point to influencing factors such as high antiseizure
by60%(from0.2perhto0.08perh),butnotattheexpenseofsen- medication(ASM)doseandshortseizureduration.
sitivity,whichremainedroughlythesameandcomparabletothat
validatedintheadultpopulation[26].Anotherphase3study[31] 4.Discussion
usedaudio–videoanalysisforautomatedreal-timeseizuredetec-
tionandshowedhighsensitivity(93.7%)fornocturnalmajormotor Morethantwelvethousandpapershavebeenpublishedonsei-
seizures, especially tonic-clonic seizures (100%), which makes it zure detection. However, most of them are strongly affected by
suitable for nocturnal surveillance, allowing rapid intervention. numeroussourcesofpotentialbias,providingatoo-optimisticper-
While the majority ofphase-3 trials have investigatedthe detec- spective, which has caused much confusion in this field. In part,
tion of major motor seizures, there was one prospective phase-3 this was due to a lack of standards for clinical validation studies
studythatassessedthedetectionofabsenceseizureswithawear- ofseizuredetectiondevices.Byapplyingthestandardsforclinical
able, single-channel EEG headband, including automated behav- validationstudies[20],potentialbiascanbereduced,andthequal-
ioral testing [29]. Their results show an average sensitivity of ityofthecontinuouslygrowingnumberofstudiesinthisfieldcan
78.8%(median92.9%),andalthoughtheysawarelativelyhighfalse beassessedandcompared.
3P.MeritamLarsenandSándorBeniczky Epilepsy&Behavior148(2023)109486
Table1
Seizuredetectiondevicesvalidatedinphase-3clinicalstudies.
Study Modality Numberofpatients/ Sensitivity FAR Detection
numberofseizures latency
Beniczkyetal.,2013[25] Accelerometry 73/39 90%forTCS 0.2/day 55seconds
Arendsetal.,2018[26] Accelerometry&heartrate 28/377 81%forTCS 0.03/night Notdetermined
Beniczkyetal.,2018 Surfaceelectromyography 71/32 94%forTCS 0.7/day(0.01/night) 9seconds
[27]
Onoratietal.,2021* Accelerometry& 152/36 Children:92% Children:1.26/day 37seconds
[28] electrodermalactivity Adults:94%,forTCS. Adults:0.57/day.
Noneduringrestperiods.
Japaridzeetal.,2022* WearableEEG-headband 39/364absenceseizures average78.8% 0.53/h 5seconds
[29] median92.9%,for
absenceseizures
Lazeronetal.,2022* Accelerometry&heartrate 23/1710 Beforeadjustment:79.9% Beforeadjustment:0.2/h 7seconds
[30] After:79.4%forTCS After:0.08/h
ArmandLarsenetal.,2022* Audio-videosystem 191/16majormotorsz TCS100% 0.16/h Notreported
[31] +336minormotorsz HMS80%
MMS8.3%
*PublishedaftertheILAE-IFCNguideline.TCS–tonic-clonicseizures(incl.generalizedandfocaltobilateral);HMS–hypermotorseizures;MMS–minormotorseizures.
Whereasreal-timealarmsareneededforsafetyindications(im- andsomeofthealgorithmsmayneedtobefine-tunedforindivid-
mediateinterventiontodecreasemorbidityandmortalityassoci- ual patients, recording the patient´s habitual seizures might be
ated with seizures), offline (post hoc) analysis or a semi- neededinthefuturetotailorseizuredetectionfortheindividual
automatedapproachcanbeusedforseizureburdenquantification patient.Selectingandfine-tuningtheseizuredetectiondevicefor
[28,51,59,60]. This means that the intent of use of the seizure theindividualpatientmightbeanewtypeofindicationfordoing
detection device defines its mode of operation (real-time alarm video-EEGrecordinginthefuture.
vs.offlineprocessing). Objective seizure quantification is challenging because it
UsingtheGRADEmethod[61,62],theILAE-IFCNworkinggroup requires a high precision of seizure identification. This has not
developedaclinicalpracticeguidelineonautomatedseizuredetec- yet been achieved with the currently available devices: although
tion using wearable devices, which has been endorsed by both they have high sensitivity (for detecting tonic-clonic seizures),
societies[18,19].Itrecommends‘‘usingclinicallyvalidatedwear- the relatively high number of false alarms precludes using them
abledevicesforautomateddetectionoftonic-clonicseizureswhen forseizurequantification.Therefore,newstrategieshavebeencon-
significant safety concerns exist, especially in unsupervised sidered.Asopposedtoseizurealarms,quantificationdoesnotneed
patientswhodonotshareabedroombutwherealarmscanresult real-time analysis. Off-line (post hoc) analysis allows the use of
inrapidinterventionwithin5minutes”. powerful cloud computing and artificial intelligence [59], and
The recommendation was conditional, restricted to a single alternative detection-threshold values (different from alarm
indication(safety),andonlyfortonic-clonicseizures.Theworking thresholds) [28], which can potentially increase precision. It also
groupconsideredthatthepublishedevidencedidnotjustifyposi- allows the use of a hybrid (semi-automated) approach, where
tive recommendations for other indications (such as objective experts review the epochs marked as potential seizures by the
quantificationoftheseizureburden)andotherseizuretypes.The algorithm [51,60]. This way, experts ensure high accuracy, and
guideline is expected to be updated every two years. Since then, algorithmsminimizetheworkload.
twophase-4studies,fourphase-3studies,and24phase-2studies Inconclusion,atpresent,thepublishedliteraturesupportsthe
have been published, but they only provide incremental knowl- useofwearabledevicesforautomatedseizuredetectioninpatients
edge and would not change the current recommendations. The withtonic-clonicseizuresforsafetyindications,asspecifiedinthe
onlyareawherenewapplicationsseemtobejustifiedisthequan- clinical practice guidelines issued by the ILAE and IFCN. Further
tification of absence seizures using wearable single-channel EEG. researchanddevelopmentareneededforotherseizuretypesand
However, only a single phase-3 study [29] supports this applica- indications.
tion, and the clinical utility of the information provided by the
devicesstillneedstobeconfirmed.
There is a need for further research and development in this Funding
field.Severalnewapproacheshavethepotentialtosolvethecur-
rentimpediments,namelyextendingtheapplicabilityofwearable This study was supported by a grant from the Independent
devices to detecting non-convulsive seizures [63] and providing ResearchFundDenmark(grantnumber0134-00400B).
objective seizure quantification and characterization [11].
Although compelling evidence is not yet available for these
approaches, they deserve more attention as they may provide Declarationofcompetinginterest
breakthroughresults.
Wearable EEG devices record probably the best signal type in Theauthorsdeclarethattheyhavenoknowncompetingfinan-
the detection of non-convulsive seizures, yet they must be con- cial interests or personal relationships that could have appeared
cealedtoavoidstigma.ThisispossibleusingportableEEGdevices toinfluencetheworkreportedinthispaper.
with non-invasive (behind-the-ear) [29,44,45,51] or minimally
invasive (subcutaneous) electrodes [64–67]. Modalities based on
ictal autonomic changes (heart rate variability, electrodermal AppendixA.Supplementarydata
activity)maydetectnon-convulsiveseizures,aloneorincombina-
tion(multimodaldevices)[24,43,55,68].Aspatientsmayneeddif- Supplementary data to this article can be found online at
ferentdevicesdependingontheirseizuretypesandcharacteristics, https://doi.org/10.1016/j.yebeh.2023.109486.
4P.MeritamLarsenandSándorBeniczky Epilepsy&Behavior148(2023)109486
References [24] JeppesenJ,Fuglsang-FrederiksenA,JohansenP,ChristensenJ,WüstenhagenS,
Tankisi H, et al. Seizure detection based on heart rate variability using a
wearableelectrocardiographydevice.Epilepsia2019;60(10):2105–13.https://
[1] Hampton T. Recent advances in mobile technology benefit global health,
doi.org/10.1111/epi.16343[Epub2019Sep20PMID:31538347].
research, and care. J Am Med Assoc 2012;307(19):2013–4. https://doi.org/
[25] BeniczkyS,PolsterT,KjaerTW,HjalgrimH.Detectionofgeneralizedtonic-
10.1001/jama.2012.4465.
clonicseizuresbyawirelesswristaccelerometer:aprospective,multicenter
[2] Lassalle-Lagadec S, Allard M, Dilharreguy B, Schweitzer P, Swendsen J,
study.Epilepsia2013;54(4):e58–61.
Sibon I. Linking MRI to daily life experience: the example of poststroke
[26] Arends J, Thijs RD, Gutter T, Ungureanu C, Cluitmans P, Van Dijk J, et al.
depression. Neurology 2012;78(5):322–5. https://doi.org/10.1212/WNL.
Multimodalnocturnalseizuredetectioninaresidentialcaresetting:along-
0b013e31824528b2.
term prospective trial. Neurology. 2018;91(21):e2010–9. https://doi.org/
[3] AbbasiJ.Mobiledeviceapphelpsdistinguishtoddlerswithautism.JAmMed
10.1212/WNL.0000000000006545 [Epub 2018 Oct 24. PMID: 30355702;
Assoc2021;325(22):2243.https://doi.org/10.1001/jama.2021.8627.
PMCID:PMC6260200].
[4] HoppeC,FeldmannM,BlachutB,SurgesR,ElgerCE,HelmstaedterC.Novel
[27] BeniczkyS,ConradsenI,HenningO,FabriciusM,WolfP.Automatedreal-time
techniques for automated seizure registration: patients’ wants and needs.
detectionoftonic-clonicseizuresusing awearable EMGdevice. Neurology
EpilepsyBehav2015;52:1–7.https://doi.org/10.1016/j.yebeh.2015.08.006.
2018;90(5):e428–34.
[5] VandeVelA,SmetsK,WoutersK,CeulemansB.Automatednon-EEGbased
[28] Onorati F, Regalia G, Caborni C, LaFrance Jr WC, Blum AS, Bidwell J, et al.
seizure detection: do users have a say? Epilepsy Behav 2016;62:121–8.
Prospective study of a multimodal convulsive seizure detection wearable
https://doi.org/10.1016/j.yebeh.2016.06.029.
systemonpediatricandadultpatientsintheepilepsymonitoringunit.Front
[6] TovarQuirogaDF,BrittonJW,WirrellEC.Patientandcaregiverviewonseizure
Neurol2021;18(12):.https://doi.org/10.3389/fneur.2021.724904724904.
detection devices: a survey study. Seizure 2016;41:179–81. https://doi.org/
[29] JaparidzeG,LoeckxD,BuckinxT,ArmandLarsenS,ProostR,JansenK,etal.
10.1016/j.seizure.2016.08.004.
Automated detection of absence seizures using a wearable
[7] PatelAD,MossR,RustSW,Patterson J,StrouseR,Gedela S,etal.Patient-
electroencephalographicdevice:aphase3validationstudyandfeasibilityof
centereddesigncriteriaforwearableseizuredetectiondevices.EpilepsyBehav
automated behavioral testing. Epilepsia 2022. https://doi.org/10.1111/
2016;64:116–21.https://doi.org/10.1016/j.yebeh.2016.09.012.
epi.17200[Epubaheadofprint.PMID:35176173].
[8] Bruno E, Simblett S, Lang A, Biondi A, Odoi C, Schulze-Bonhage A, et al.
[30] Lazeron RHC, Thijs RD, Arends J, Gutter T, Cluitmans P, Van Dijk J, et al.
Wearable technology in epilepsy: the views of patients, caregivers, and
Multimodalnocturnalseizuredetection:doweneedtoadaptalgorithmsfor
healthcareprofessionals.EpilepsyBehav.2018;85:141-149.https://doi.org/
children? Epilepsia Open 2022;7(3):406–13. https://doi.org/10.1002/
10.1016/j.yebeh.2018.05.044[Epub2018Jun23.PMID:29940377].
epi4.12618[Epub2022Jul21.PMID:35666848;PMCID:PMC9436288].
[9] ElgerCE,HoppeC.Diagnosticchallengesinepilepsy:seizureunder-reporting
[31] ArmandLarsenS,TerneyD,ØsterkjerhuusT,VindingMerinderT,AnnalaK,
andseizuredetection.LancetNeurol2018;17(3):279–88.
KnightA,etal. Automated detectionofnocturnalmotorseizures usingan
[10] RyvlinP,CiumasC,WisniewskiI,BeniczkyS.Wearabledevicesforsudden
audio-video system. Brain Behav 2022;12(9). https://doi.org/10.1002/
unexpecteddeathinepilepsyprevention.Epilepsia2018;59(Suppl1):61–6.
brb3.2737[Epub2022Aug8.PMID:35939047;PMCID:PMC9480955].
https://doi.org/10.1111/epi.14054.
[32] van Westrhenen A, Lazeron RHC, van Dijk JP, Leijten FSS, Thijs RD, Dutch
[11] BeniczkyS,ArbuneAA,JeppesenJ,RyvlinP.Biomarkersofseizureseverity
TeleEpilepsyConsortium.Multimodalnocturnalseizuredetectioninchildren
derivedfromwearabledevices.Epilepsia2020;61(Suppl1):S61–6.https://doi.
withepilepsy:aprospective,multicenter,long-term,in-hometrial.Epilepsia.
org/10.1111/epi.16492.
2023. https://doi.org/10.1111/epi.17654 [Epub ahead of print. PMID:
[12] Salas-PuigX,IniestaM,AbrairaL,PuigJ.QUIN-GTCstudygroup.Accidental
37195144].
injuries in patients with generalized tonic-clonic seizures. A multicenter,
[33] HadadyL,KlivényiP,FabóD,BeniczkyS.Real-worlduserexperiencewith
observational, cross-sectional study (QUIN-GTC study). Epilepsy Behav
seizuredetectionwearabledevicesinthehomeenvironment.Epilepsia2022.
2019;92:135–9.https://doi.org/10.1016/j.yebeh.2018.10.043 [Epub2019Jan
https://doi.org/10.1111/epi.17189[Epubaheadofprint.PMID:35195898].
15.PMID:30658321].
[34] MaceaJ,BhagubaiM,BrouxV,DeVosM,VanPaesschenW.In-hospitaland
[13] RyvlinP,NashefL,LhatooSD,BatemanLM,BirdJ,BleaselA,etal.Incidence
home-based long-term monitoring of focal epilepsy with a wearable
and mechanisms of cardiorespiratory arrests in epilepsy monitoring units
electroencephalographic device: diagnostic yield and user experience.
(MORTEMUS): a retrospective study. Lancet Neurol 2013;12(10):966–77.
Epilepsia 2023;64(4):937–50. https://doi.org/10.1111/epi.17517 [Epub 2023
https://doi.org/10.1016/S1474-4422(13)70214-X [Epub 2013 Sep 4 PMID:
Feb3PMID:36681896].
24012372].
[35] EngelgeerA,vanWestrhenenA,ThijsRD,EversSMAA.Aneconomicevaluation
[14] Sveinsson O, Andersson T, Mattsson P, Carlsson S, Tomson T. Clinical risk
oftheNightWatchforchildrenwithrefractoryepilepsy:insightintothecost-
factors in SUDEP: a nationwide population-based case-control study.
effectiveness and cost-utility. Seizure 2022;101:156–61. https://doi.org/
Neurology. 2020;94(4):e419–29. https://doi.org/10.1212/
10.1016/j.seizure.2022.08.003.Epub2022Aug17PMID:36030593.
WNL.0000000000008741 [Epub 2019 Dec 12. Erratum in:Neurology. 2020
[36] TangJ,ElAtracheR,YuS,AsifU,JacksonM,RoyS,etal.Seizuredetectionusing
Mar10;94(10):459.PMID:31831600;PMCID:PMC7079690].
wearable sensors and machine learning: setting a benchmark. Epilepsia
[15] HardenC,TomsonT,GlossD,BuchhalterJ,CrossJH,DonnerE,etal.Epilepsy
2021;62(8):1807–19.https://doi.org/10.1111/epi.16967.
Curr 2017;17(3):180–7. https://doi.org/10.5698/1535-7511.17.3.180 [PMID:
[37] BöttcherS,BrunoE,ManyakovNV,EpitashviliN,ClaesK,GlasstetterM,etal.
28684957;PMCID:PMC5486432].
Detectingtonic-clonicseizuresinmultimodalbiosignaldatafromwearables:
[16] Cook MJ, O’Brien TJ, Berkovic SF, Murphy M, Morokoff A, Fabinyi G, et al.
methodology design and validation. JMIR Mhealth Uhealth 2021;9(11):
Predictionofseizurelikelihoodwithalong-term,implantedseizureadvisory
e27674. https://doi.org/10.2196/27674 [PMID: 34806993; PMCID:
systeminpatientswithdrug-resistantepilepsy:afirst-in-manstudy.Lancet
PMC8663471].
Neurol 2013;12(6):563–71. https://doi.org/10.1016/S1474-4422(13)70075-9
[38] GlasstetterM,BöttcherS,ZablerN,EpitashviliN,DümpelmannM,Richardson
[Epub2013May2PMID:23642342].
MP,etal.Identificationofictaltachycardiainfocalmotor-andnon-motor
[17] HoppeC,PoepelA,ElgerCE.Epilepsy:accuracyofpatientseizurecounts.Arch
seizures by means of a wearable PPG sensor. Sensors (Basel) 2021;21
Neurol2007;64(11):1595–9.
(18):6017. https://doi.org/10.3390/s21186017 [PMID: 34577222; PMCID:
[18] Beniczky S, Wiebe S, Jeppesen J, Tatum WO, Brazdil M, Wang Y, et al.
PMC8470979].
Automated seizure detection using wearable devices: a clinical practice
[39] Jahanbekam A, Baumann J, Nass RD, Bauckhage C, Hill H, Elger CE, et al.
guidelineoftheInternationalLeagueAgainstEpilepsyandtheInternational
PerformanceofECG-basedseizuredetectionalgorithmsstronglydependson
FederationofClinicalNeurophysiology.Epilepsia2021;62(3):632–46.https://
trainingandtestconditions.EpilepsiaOpen2021;6(3):597–606.https://doi.
doi.org/10.1111/epi.16818.
org/10.1002/epi4.12520.
[19] Beniczky S, Wiebe S, Jeppesen J, Tatum WO, Brazdil M, Wang Y, et al.
[40] Hegarty-CraverM,KronerBL,BumbutA,DeFilippSJ,GaillardWD,GilchristKH.
Automated seizure detection using wearable devices: a clinical practice
Cardiac-baseddetectionofseizuresinchildrenwithepilepsy.EpilepsyBehav
guidelineoftheInternationalLeagueAgainstEpilepsyandtheInternational
2021;122:.https://doi.org/10.1016/j.yebeh.2021.108129108129.
Federation of Clinical Neurophysiology. Clin Neurophysiol 2021;132
[41] DeCoomanT,VandecasteeleK,VaronC,HunyadiB,CleerenE,VanPaesschen
(5):1173–84.https://doi.org/10.1016/j.clinph.2020.12.009[Epub2021Mar5].
W,et al.Personalizing heart rate-based seizure detection usingsupervised
[20] BeniczkyS,RyvlinP.Standardsfortestingandclinicalvalidationofseizure
SVMtransferlearning.FrontNeurol2020;26(11):145.https://doi.org/10.3389/
detectiondevices.Epilepsia2018;59(Suppl1):9–13.https://doi.org/10.1111/
fneur.2020.00145.
epi.14049.
[42] JeppesenJ,Fuglsang-FrederiksenA,JohansenP,ChristensenJ,WüstenhagenS,
[21] WhitingPF,RutjesAWS,WestwoodME,MallettS,DeeksJJ,ReitsmaJB,etal.
TankisiH,etal.Seizuredetectionusingheartratevariability:aprospective
QUADAS-2:arevisedtoolforthequalityassessmentofdiagnosticaccuracy
validationstudy.Epilepsia2020;61(Suppl1):S41–6.https://doi.org/10.1111/
studies.AnnInternMed2011;155(8):529.
epi.16511.
[22] MeritamP,RyvlinP,BeniczkyS.User-basedevaluationofapplicabilityand
[43] Jeppesen J, Christensen J, Johansen P, Beniczky S. Personalized seizure
usability of a wearable accelerometer device for detecting bilateral tonic-
detectionusinglogisticregressionmachinelearningbasedonwearableECG-
clonicseizures:afieldstudy.Epilepsia2018;59(Suppl1):48–52.https://doi.
monitoring device. Seizure 2023;107:155–61. https://doi.org/10.1016/
org/10.1111/epi.14051.
j.seizure.2023.04.012[Epub2023Apr13PMID:37068328].
[23] BoonP,VonckK,vanRijckevorselK,ElTahryR,ElgerCE,MullattiN,etal.A
[44] VandecasteeleK,DeCoomanT,DanJ,CleerenE,VanHuffelS,HunyadiB,etal.
prospective,multicenterstudyofcardiac-basedseizuredetectiontoactivate
Visualseizureannotationandautomatedseizuredetectionusingbehind-the-
vagus nerve stimulation. Seizure 2015;32:52–61. https://doi.org/10.1016/
earelectroencephalographicchannels.Epilepsia2020;61(4):766–75.https://
j.seizure.2015.08.011[Epub2015Sep21PMID:26552564].
doi.org/10.1111/epi.16470.
5P.MeritamLarsenandSándorBeniczky Epilepsy&Behavior148(2023)109486
[45] YouS,ChoBH,YookS,KimJY,ShonYM,SeoDW,etal.Unsupervisedautomatic [56] Nielsen JM, Kristinsdóttir ÁE, Zibrandtsen IC, Masulli P, Ballegaard M,
seizuredetectionforfocal-onsetseizuresrecordedwithbehind-the-earEEG Andersen TS, et al. Out-of-hospital multimodal seizure detection: a pilot
using an anomaly-detecting generative adversarial network. Comput study.BMJNeurolOpen2023;5(2):e000442.https://doi.org/10.1136/bmjno-
Methods Programs Biomed 2020;193:. https://doi.org/10.1016/j.cmpb.2020. 2023-000442[PMID:37547054;PMCID:PMC10401242].
105472105472. [57] Pipatpratarnporn W, Muangthong W, Jirasakuldej S, Limotai C. Wrist-worn
[46] VandecasteeleK,DeCoomanT,ChatzichristosC,CleerenE,SwinnenL,Macea smartwatchandpredictivemodels forseizures.Epilepsia2023.https://doi.
Ortiz J, et al. The power of ECG in multimodal patient-specific seizure org/10.1111/epi.17729[Epubaheadofprint.PMID:37505115].
monitoring: added value to an EEG-based detector using limited channels. [58] HalimehM,JacksonM,VielufS,LoddenkemperT,MeiselC.ExplainableAIfor
Epilepsia2021.https://doi.org/10.1111/epi.16990. wearableseizurelogging:impactofdataquality,patientage,andantiseizure
[47] BhagubaiM,VandecasteeleK,SwinnenL,MaceaJ,ChatzichristosC,DeVosM, medication on performance. Seizure 2023;110:99–108. https://doi.org/
etal.ThepowerofECGinsemi-automatedseizuredetectioninadditionto 10.1016/j.seizure.2023.06.002[Epub2023Jun8PMID:37336056].
two-channel behind-the-ear EEG. Bioengineering (Basel) 2023;10(4):491. [59] BeniczkyS,KarolyP,NurseE,RyvlinP,CookM.Machinelearningandwearable
https://doi.org/10.3390/bioengineering10040491 [PMID: 37106678; PMCID: devicesofthefuture.Epilepsia2020.https://doi.org/10.1111/epi.16555.
PMC10136326]. [60] Husain AM, Towne AR, Chen DK, Whitmire LE, Voyles SR, Cardenas DP.
[48] vanWestrhenenA,PetkovG,KalitzinSN,LazeronRHC,ThijsRD.Automated Differentiation of epileptic and psychogenic nonepileptic seizures using
video-based detection of nocturnal motor seizures in children. Epilepsia single-channelsurfaceelectromyography.JClinNeurophysiol2020.https://
2020;61(Suppl1):S36–40.https://doi.org/10.1111/epi.16504. doi.org/10.1097/WNP.0000000000000703.
[49] BasnyatP,MäkinenJ,SaarinenJT,PeltolaJ.Clinicalutilityofavideo/audio- [61] GuyattGH,OxmanAD,VistGE,KunzR,Falck-YtterY,Alonso-CoelloP,etal.
basedepilepsymonitoringsystemNelli.EpilepsyBehav2022;133:.https:// GRADE:anemergingconsensusonratingqualityofevidenceandstrengthof
doi.org/10.1016/j.yebeh.2022.108804. Epub 2022 Jun 23 PMID: recommendations.ChinJEvid-BasedMedBMJ2009;9:8–11.
35753111108804. [62] Handbook for grading the quality of evidence and the strength of the
[50] RissanenSM,HyppönenJ,SilvennoinenK,SäisänenL,KarjalainenPA,Mervaala recommendations using the GRADE approach [Internet]. 2013. https://
E, et al. Wearable monitoring of positive and negative myoclonus in gdt.gradepro.org/app/handbook/handbook.html.Accessedon27May2020.
progressive myoclonic epilepsy type 1. Clin Neurophysiol 2021;132 [63] RyvlinP,CammounL,HubbardI,RaveyF,BeniczkyS,AtienzaD.Noninvasive
(10):2464–72. https://doi.org/10.1016/j.clinph.2021.06.026 [Online ahead of detectionoffocalseizuresinambulatorypatients.Epilepsia2020;61(Suppl1):
print]. S47–54.https://doi.org/10.1111/epi.16538.
[51] SwinnenL,ChatzichristosC,JansenK,LagaeL,DepondtC,SeynaeveL,etal. [64] WeisdorfS,Duun-HenriksenJ,KjeldsenMJ,PoulsenFR,GangstadSW,Kjaer
Accuratedetectionoftypicalabsenceseizuresinadultsandchildrenusinga TW.Ultra-long-termsubcutaneoushomemonitoringofepilepsy-490daysof
two-channel electroencephalographic wearable behind the ears. Epilepsia EEG from nine patients. Epilepsia 2019;60(11):2204–14. https://doi.org/
2021.https://doi.org/10.1111/epi.17061. 10.1111/epi.16360.
[52] BrotherstoneR,McLellanA,GrahamC,FisherK.Aclinicalevaluationofanovel [65] WeisdorfS,ZibrandtsenIC,KjaerTW.SubcutaneousEEGmonitoringreveals
algorithm in the reliable detection of epileptic seizures. Seizure AED response and breakthrough seizures. Case Rep Neurol Med 2020;28
2020;82:109–17.https://doi.org/10.1016/j.seizure.2020.09.017. (2020):8756917.https://doi.org/10.1155/2020/8756917.
[53] FrankelMA, LehmkuhleMJ, Spitz MC,Newman BJ,Richards SV,Arain AM. [66] Duun-HenriksenJ,BaudM,RichardsonMP,CookM,KouvasG,HeasmanJM,
Wearablereduced-channelEEGsystemforremoteseizuremonitoring.Front etal.Anewerainelectroencephalographicmonitoring?Subscalpdevicesfor
Neurol 2021;18(12):. https://doi.org/10.3389/fneur.2021.728484 [PMID: ultra-long-term recordings. Epilepsia 2020;61(9):1805–17. https://doi.org/
34733229;PMCID:PMC8558398]728484. 10.1111/epi.16630.
[54] ChenH,WangZ,LuC,ShuF,ChenC,WangL,etal.Neonatalseizuredetection [67] VianaPF,RemvigLS,Duun-HenriksenJ,GlasstetterM,DümpelmannM,Nurse
usingawearablemulti-sensorsystem.Bioengineering(Basel)2023;10(6):658. ES,etal.Signalqualityandpowerspectrumanalysisofremoteultralong-term
https://doi.org/10.3390/bioengineering10060658 [PMID: 37370589; PMCID: subcutaneous EEG. Epilepsia 2021;62(8):1820–8. https://doi.org/10.1111/
PMC10294985]. epi.16969.
[55] JeppesenJ,ChristensenJ,MølgaardH,BeniczkyS.Automateddetectionoffocal [68] VielufS,Amengual-GualM,ZhangB,ElAtracheR,UfongeneC,JacksonMC,
seizuresusingsubcutaneouslyimplantedelectrocardiographicdevice:aproof- et al. Twenty-four-hour patterns in electrodermal activity recordings of
of-concept study. Epilepsia 2023. https://doi.org/10.1111/epi.17612 [Epub patients with and without epileptic seizures. Epilepsia 2021;62(4):960–72.
aheadofprint.PMID:37029748]. https://doi.org/10.1111/epi.16843.
6